TuHURA BIOSCIENCES, INC./NV Share-based Payment Arrangement, Accelerated Cost
TuHURA BIOSCIENCES, INC./NV (HURA) reported Share-based Payment Arrangement, Accelerated Cost of $53.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2021-09-28
- TuHURA BIOSCIENCES, INC./NV share-based payment arrangement, accelerated cost for the quarter ending 2021-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV share-based payment arrangement, accelerated cost for the quarter ending 2021-03-31 was -$53.40M.
- TuHURA BIOSCIENCES, INC./NV share-based payment arrangement, accelerated cost for fiscal 2021 was $53.00K.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | -$53.40M derived: sum of 2 quarters · filed 2021-09-28 | $53.00K 10-K · filed 2021-09-28 | |
| 2021-03-31 | -$53.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $53.00K 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $53.45M 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |